🇪🇺 EVARREST® Fibrin Sealant Patch in European Union

EMA authorised EVARREST® Fibrin Sealant Patch on 25 September 2013

Marketing authorisation

EMA — authorised 25 September 2013

  • Application: EMEA/H/C/002515
  • Marketing authorisation holder: Omrix Biopharmaceuticals N. V.
  • Local brand name: Evarrest
  • Indication: Supportive treatment in adult surgery where standard surgical techniques are insufficient (see section 5.1): - for improvement of haemostasis.
  • Status: withdrawn

Read official source →

EVARREST® Fibrin Sealant Patch in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is EVARREST® Fibrin Sealant Patch approved in European Union?

Yes. EMA authorised it on 25 September 2013.

Who is the marketing authorisation holder for EVARREST® Fibrin Sealant Patch in European Union?

Omrix Biopharmaceuticals N. V. holds the EU marketing authorisation.